{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:27:59Z","timestamp":1773365279146,"version":"3.50.1"},"reference-count":14,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"Sp. 2","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100022965","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["1115-569-34430"],"award-info":[{"award-number":["1115-569-34430"]}],"id":[{"id":"10.13039\/100022965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022965","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["1115-569-34430"],"award-info":[{"award-number":["1115-569-34430"]}],"id":[{"id":"10.13039\/100022965","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["Biomed."],"abstract":"<jats:p>Introduction. Common variable immunodeficiency is a diagnosis of exclusion in immunodeficient patients with increased susceptibility to infections,hypogammaglobulinemia, deficient response to vaccination, or low percentages of switched memory B cells. In low- and middle-income countries, the elucidation and study of molecular defects in these patients may take decades.Objective. To elucidate the genetic defect conferring impaired immunity in a patient diagnosed with common variable immunodeficiency.Materials and methods. The clinical phenotype was extracted from the clinical records. NKG2D expression in natural killer cells was evaluated by flow cytometry. The whole exome sequencing was performed in the patient and his parents. Sanger sequencing confirmed the pathogenic variant.Results. The patient suffered from upper respiratory and urinary tract infections, autoimmune hemolytic anemia, and hepatopathy. NKG2D was decreased in the differentblood subpopulations of natural killer cells. Serologic and viral load studies for Epstein-Barr virus were positive, but no B-cell malignancies have been documented. The patient presented a nonsense variant in the exon 3 of the MAGT1 gen (c.409C&gt;T, rs387906724) in the X chromosome, resulting in an amino acid substitution of arginine for a stop codon in the position 137 of the protein (R137X). The mother also carried the pathogenic variant in a heterozygous state.Conclusions. We report the clinical case of the first Colombian male patient with a pathogenic variant in MAGT1 associated with XMEN disease. Genetic counseling and followup are recommended for families with similar cases to allow prompt detection of new cases.<\/jats:p>","DOI":"10.7705\/biomedica.7636","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T15:50:52Z","timestamp":1736437852000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Loss-of-function variant in MAGT1 leading to XMEN disease in a Colombian patient with a common variable immunodeficiency","Variante con p\u00e9rdida de funci\u00f3n en MAGT1 causante de la enfermedad de XMEN en un paciente colombiano con inmunodeficiencia com\u00fan variable"],"prefix":"10.7705","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1576-595X","authenticated-orcid":false,"given":"Sebasti\u00e1n","family":"Guti\u00e9rrez-Hincapi\u00e9","sequence":"first","affiliation":[{"name":"Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia, Medell\u00edn, Colombia"},{"name":"Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia, Medell\u00edn, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3809-9187","authenticated-orcid":false,"given":"Julio C\u00e9sar","family":"Orrego","sequence":"additional","affiliation":[{"name":"Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia, Medell\u00edn, ColombiaGrupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia, Medell\u00edn, Colombia"},{"name":"Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia, Medell\u00edn, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5664-6415","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Franco","sequence":"additional","affiliation":[{"name":"Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia, Medell\u00edn, Colombia"},{"name":"Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia, Medell\u00edn, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8546-2666","authenticated-orcid":false,"given":"Claudia M.","family":"Trujillo-Vargas","sequence":"additional","affiliation":[{"name":"Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia, Medell\u00edn, Colombia"},{"name":"Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia, Medell\u00edn, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4444","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"141663","doi-asserted-by":"crossref","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. Human inborn errors of immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42:1473-507. https:\/\/doi.org\/10.1007\/s10875-022-01289-3","DOI":"10.1007\/s10875-022-01289-3"},{"key":"141664","doi-asserted-by":"crossref","unstructured":"Peng XP, Caballero-Oteyza A, Grimbacher B. Common variable immunodeficiency: More pathways than roads to Rome. Annu Rev Pathol. 2023;18:283-310. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031521-024229","DOI":"10.1146\/annurev-pathmechdis-031521-024229"},{"key":"141665","doi-asserted-by":"crossref","unstructured":"Poli A, Michel T, Th\u00e9r\u00e9sine M, Andr\u00e8s E, Hentges F, Zimmer J. CD56 bright natural killer (NK) cells: An important NK cell subset. Immunol. 2009;126:458-65. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.03027.x","DOI":"10.1111\/j.1365-2567.2008.03027.x"},{"key":"141666","doi-asserted-by":"crossref","unstructured":"Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93:190-7. https:\/\/doi.org\/10.1006\/clim.1999.4799","DOI":"10.1006\/clim.1999.4799"},{"key":"141667","doi-asserted-by":"crossref","unstructured":"Schatorj\u00e9 EJ, Gemen EF, Driessen GJ, Leuvenink J, van Hout RW, de Vries E. Paediatric reference values for the peripheral T cell compartment. Scand J Immunol. 2012;75:436-44. https:\/\/doi.org\/10.1111\/j.1365-3083.2012.02671.x","DOI":"10.1111\/j.1365-3083.2012.02671.x"},{"key":"141668","doi-asserted-by":"crossref","unstructured":"Morbach H, Eichhorn EM, Liese JG, Girschick HJ. Reference values for B cell subpopulations from infancy to adulthood. Clin Exp Immunol. 2010;162:271-9. https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04206.x","DOI":"10.1111\/j.1365-2249.2010.04206.x"},{"key":"141669","doi-asserted-by":"crossref","unstructured":"Robbins JB, Austrian R, Lee CJ, Rastogi SC, Schiffman G, Henrichsen J, et al. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis. 1983;148:1136-59. https:\/\/doi.org\/10.1093\/infdis\/148.6.1136","DOI":"10.1093\/infdis\/148.6.1136"},{"key":"141670","unstructured":"Garc\u00eda de Olarte D, Posada LH, Garc\u00eda LF, Cardona R. Niveles de inmunoglobulinas s\u00e9ricas en poblaci\u00f3n normal de Medell\u00edn. Acta Med Colomb. 1984;9:45."},{"key":"141671","doi-asserted-by":"crossref","unstructured":"Li FY, Chaigne-Delalande B, Kanellopoulou C, Davis JC, Matthews HF, Douek DC, et al. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature. 2011;475:471-6. https:\/\/doi.org\/10.1038\/nature10246","DOI":"10.1038\/nature10246"},{"key":"141672","doi-asserted-by":"crossref","unstructured":"Chaigne-Delalande B, Li FY, O\u2019Connor GM, Lukacs MJ, Jiang P, Zheng L, et al. Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science. 2013;341:186-91. https:\/\/doi.org\/10.1126\/science.1240094","DOI":"10.1126\/science.1240094"},{"key":"141673","doi-asserted-by":"crossref","unstructured":"Ravell JC, Matsuda-Lennikov M, Chauvin SD, Zou J, Biancalana M, Deeb SJ, et al. Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease. J Clin Invest. 2020;130:507-22. https:\/\/doi.org\/10.1172\/JCI131116","DOI":"10.1172\/JCI131116"},{"key":"141674","unstructured":"Edgar D, Ehl S. The European Society for Immunodeficiencies (ESID) Registry - Working definitions for clinical diagnosis of PID. Accessed: October 9, 2024. Available at: https:\/\/esid.org\/content\/download\/13053\/372959\/file\/ESIDRegistry_ClinicalCriteriapdf"},{"key":"141675","doi-asserted-by":"crossref","unstructured":"Brault J, Liu T, Bello E, Liu S, Sweeney CL, Meis RJ, et al. CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytes. Blood. 2021;138:2768-80. https:\/\/doi.org\/10.1182\/blood.2021011192","DOI":"10.1182\/blood.2021011192"},{"key":"141676","doi-asserted-by":"crossref","unstructured":"Torgerson TR. Is this a cure for XMEN? Blood. 2021;138:2743-4. https:\/\/doi.org\/10.1182\/blood.2021012755","DOI":"10.1182\/blood.2021012755"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7636\/5640","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7636\/5724","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7636\/5640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:04:12Z","timestamp":1773320652000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/7636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":14,"journal-issue":{"issue":"Sp. 2","published-online":{"date-parts":[[2024,12,23]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.7636","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"2024-12-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Presentaci\u00f3n de caso","name":"content_type","label":"Content Type"}]}}